Covaxin To Be Evaluated As Covid-19 Vaccine Candidate In US As USFDA Lifts Clinical Holds

Bharat Biotech on Saturday said its Covaxin will be evaluated as a COVID-19 vaccine candidate in the US. In a statement, Ocugen Inc, Bharat Biotech’s partner in the US and Canada for Covaxin, noted that the American health regulator — the
http://dlvr.it/SKLyTM